These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 17048352

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Recent evidence about aromatase in the breast carcinoma].
    Suzuki T, Moriya T, Sasano H.
    Nihon Rinsho; 2007 Jun 28; 65 Suppl 6():106-10. PubMed ID: 17682147
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A, Ribelles N, Márquez A, Pérez-Ruiz E, Alba E.
    J Clin Oncol; 2009 Dec 10; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oestrogen producing enzymes and mammary carcinogenesis: a review.
    Subramanian A, Salhab M, Mokbel K.
    Breast Cancer Res Treat; 2008 Sep 10; 111(2):191-202. PubMed ID: 17934808
    [Abstract] [Full Text] [Related]

  • 7. [Aromatase inhibitors in breast cancer therapy].
    Joensuu H.
    Duodecim; 2004 Sep 10; 120(11):1301-4. PubMed ID: 15327081
    [No Abstract] [Full Text] [Related]

  • 8. [Aromatase inhibitors for metastasing breast cancer in postmenopausal women. A survey of a Cochrane review].
    Aziz M, Skougaard K, Kamby C, Nielsen DL.
    Ugeskr Laeger; 2008 Jun 16; 170(25):2248-52. PubMed ID: 18565316
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Definition of postmenopausal status, age of the breast cancer patients and the outcome of aromatase inhibitors treatment.
    Aksoy S, Dizdar O, Altundag K.
    Breast; 2008 Oct 16; 17(5):433-5. PubMed ID: 18565752
    [No Abstract] [Full Text] [Related]

  • 11. The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence.
    Howgate DJ, Gamie Z, Panteliadis P, Bhalla A, Mantalaris A, Tsiridis E.
    Expert Opin Drug Saf; 2009 Sep 16; 8(5):523-35. PubMed ID: 19645634
    [Abstract] [Full Text] [Related]

  • 12. Emerging bone health issues in women with breast cancer in Hawai'i.
    Carney JF, Davis J.
    Hawaii Med J; 2007 Jun 16; 66(6):164-6. PubMed ID: 17621865
    [Abstract] [Full Text] [Related]

  • 13. Neoadjuvant use of endocrine therapy in breast cancer.
    Macaskill EJ, Dixon JM.
    Breast J; 2007 Jun 16; 13(3):243-50. PubMed ID: 17461898
    [Abstract] [Full Text] [Related]

  • 14. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
    Iwase H.
    Breast Cancer; 2008 Jun 16; 15(4):278-90. PubMed ID: 18810576
    [Abstract] [Full Text] [Related]

  • 15. Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials.
    Boccardo F, Rubagotti A, Aldrighetti D, Buzzi F, Cruciani G, Farris A, Mustacchi G, Porpiglia M, Schieppati G, Sismondi P.
    Cancer; 2007 Mar 15; 109(6):1060-7. PubMed ID: 17295293
    [Abstract] [Full Text] [Related]

  • 16. Aromatase and the breast: regulation and clinical aspects.
    Miller WR.
    Maturitas; 2006 Jul 20; 54(4):335-41. PubMed ID: 16730141
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Aromatase inhibitors in advanced breast cancer].
    Spinelli GP, Tomao F, Miele E, Pasciuti G, Russillo M, Tomao S.
    Recenti Prog Med; 2008 Jan 20; 99(1):34-8. PubMed ID: 18389871
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.